Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 4, 2011, Pages 740-745

  Pino Yanes, María ^a,b   Ma, Shwu Fan ^f   Sun, Xiaoguang ^b   Tejera, Paula ^c   Corrales, Almudena ^a,b   Blanco, Jesús ^a,d   Pérez Méndez, Lina ^a,b   Espinosa, Elena ^e   Muriel, Arturo ^d   Blanch, Lluis ^a,g   Garcia, Joe G N ^b   Villar, Jesús ^a,h,i   Flores, Carlos ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^g Hospital Universitari Parc Taulí   (Spain)

^h HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Case control; Polymorphism; Severe sepsis; SNP; Toll like receptor

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3;

ACUTE LUNG INJURY; ADULT; AGED; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ACUTE LUNG INJURY; ADULT; AGED; BINDING SITES; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GENE FREQUENCY; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SPAIN; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 80053652520     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0292OC     Document Type: Article

References (47)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891. (Pubitemid 36019643)
2. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis 2005;41:S490-S497. (Pubitemid 41598310)
3. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, Collado J, Garcia-Labattut A, Carriedo D, Valledor M, et al. Grupo de Estudios y Análisis en Cuidados Intensivos: incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008;12:R158.
4. Frodsham AJ, Hill AV. Genetics of infectious diseases. Hum Mol Genet 2004;13:R187-R194. (Pubitemid 39359902)
5. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005;6:167-170. (Pubitemid 40439544)
6. Aziz RK, Kansal R, Abdeltawab NF, Rowe SL, Su Y, Carrigan D, Nooh MM, Attia RR, Brannen C, Gardner LA, et al. Susceptibility to severe streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun 2007;8: 404-415. (Pubitemid 47177132)
7. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007;7:179-190.
8. Flores C, Perez-Mendez L, Maca-Meyer N, Muriel A, Espinosa E, Blanco J, Sanguesa R, Muros M, Garcia JG, Villar J. A common haplotype of the LBP gene predisposes to severe sepsis. Crit Care Med 2009;37:2759-2766.
9. Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005;33:638-644. (Pubitemid 40365568)
10. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-191. (Pubitemid 30394990)
11. Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003;170:3451-3454. (Pubitemid 36359209)
12. Kang TJ, Lee SB, Chae GT. A polymorphism in the Toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002;20:56-62. (Pubitemid 35373721)
13. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68: 6398-6401.
14. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007;39:523-528. (Pubitemid 46514767)
15. Clark MF, Baudouin SV. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 2006;32: 1706-1712. (Pubitemid 44607357)
16. Flores C, Pino-Yanes MM, Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008;12:R130.
17. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003;299:2076-2079. (Pubitemid 36383736)
18. Arcaroli J, Silva E, Maloney JP, He Q, Svetkauskaite D, Murphy JR, Abraham E. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 2006;173:1335-1341. (Pubitemid 43900707)
19. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAK-M is a novel member of the pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999;274:19403-19410.
20. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002;110:191-202. (Pubitemid 34876547)
21. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al. Inflammatory and host response to injury: large scale collaborative research program: a network-based analysis of systemic inflammation in humans. Nature 2005;437:1032-1037.
22. Escoll P, del Fresno C, Garcia L, Valles G, Lendinez MJ, Arnalich F, Lopez-Collazo E. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem Biophys Res Commun 2003;311:465-472. (Pubitemid 37340100)
23. Villar J, Cabrera N, Casula M, Flores C, Valladares F, Muros M, Slutsky AS, Kacmarek RM. Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model. Intensive Care Med 2010;36:1409-1457.
24. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, Flavell RA, Standiford TJ. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 2006;116:2532-2542. (Pubitemid 44330152)
25. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993;91:853-861. (Pubitemid 23095259)
26. Wiersinga WJ, van't Veer C, van den Pangaart PS, Dondorp AM, Day NP, Peacock SJ, van der Poll T. Immunosuppression associated with interleukin-1r-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit Care Med 2009;37: 569-576.
27. Villar J, Perez-Mendez L, Flores C, Maca-Meyer N, Espinosa E, Muriel A, Sanguesa R, Blanco J, Muros M, Kacmarek RMA. CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Crit Care Med 2007;35:2292-2297. (Pubitemid 47476226)
28. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256. (Pubitemid 36444440)
29. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824. (Pubitemid 24082248)
30. Conde L, Vaquerizas JM, Dopazo H, Arbiza L, Reumers J, Rousseau F, Schymkowitz J, Dopazo J. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 2006;34:W621-625. (Pubitemid 44529845)
31. Wang K. Testing for genetic association in the presence of population stratification in genome-wide association studies. Genet Epidemiol 2009;33:637-645.
32. Flores C, Maca-Meyer N, Perez-Mendez L, Sanguesa R, Espinosa E, Muriel A, Blanco J, Villar JA. CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population. Genes Immun 2006;7:141-149. (Pubitemid 43336056)
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, B 1995; 57:289-300.
34. Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for P-value adjustment. New York: John Wiley & Sons; 1993.
35. Wen X, Nicolae DL. Association studies for untyped markers with TUNA. Bioinformatics 2008;24:435-437. (Pubitemid 351189025)
36. Cassani B, Poliani PL, Moratto D, Sobacchi C, Marrella V, Imperatori L, Vairo D, Plebani A, Giliani S, Vezzoni P, et al. Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol 2010;125:209-216.
37. Villar J, Maca-Meyer N, Perez-Mendez L, Flores C. Bench-to-bedside review: understanding genetic predisposition to sepsis. Crit Care 2004; 8:180-189. (Pubitemid 38735697)
38. Nakashima K, Hirota T, Obara K, Shimizu M, Jodo A, Kameda M, Doi S, Fujita K, Shirakawa T, Enomoto T, et al. An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway. J Hum Genet 2006;51:284-291.
39. Balaci L, Spada MC, Olla N, Sole G, Loddo L, Anedda F, Naitza S, Zuncheddu MA, Maschio A, Altea D, et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 2007;80:1103-1114. (Pubitemid 47579346)
40. Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases. Scand J Gastroenterol 2007;42:827-833. (Pubitemid 46897626)
41. Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001;276:37672-37679.
42. Lyn-Kew K, Standiford TJ. Immunosuppression in sepsis. Curr Pharm Des 2008;14:1870-1881.
43. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum Genet 2009;125:131-151.
44. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008;322:881-888.
45. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678.
46. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe A, Rietschel E, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007;448:470-473. (Pubitemid 47123521)
47. Osuchowski MF, Connett J, Welch K, Granger J, Remick DG. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 2009;37: 1567-1573.